Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?

被引：0
|
作者：
Müller Mareike
Staub-Bartelt Franziska
Ehrmann Julia
Hänggi Daniel
Sabel Michael
Felsberg Jörg
Rapp Marion
机构：
[1] University Hospital Duesseldorf,Department of Neurosurgery
[2] University Hospital Duesseldorf,Department of Neuropathology
[3] Heinrich-Heine University Düsseldorf,Department of Neurosurgery, Medical Faculty
来源：
Journal of Neuro-Oncology | 2021年 / 153卷
关键词：
Glioblastoma; Neurooncology; MGMT; Extend of resection; Subtotal resection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：537 / 545
页数：8
相关论文
共 50 条
  • [1] Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
    Mareike, Mueller
    Franziska, Staub-Bartelt
    Julia, Ehrmann
    Daniel, Haenggi
    Michael, Sabel
    Joerg, Felsberg
    Marion, Rapp
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (03) : 537 - 545
  • [2] THE PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PARTIAL MGMT PROMOTER METHYLATION FOR IDH-WILDTYPE GLIOBLASTOMA PATIENTS
    Torre, Matthew
    Iorgulescu, Bryan
    NEURO-ONCOLOGY, 2022, 24 : 10 - 10
  • [3] The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
    Incekara, Fatih
    Smits, Marion
    van der Voort, Sebastian R.
    Dubbink, Hendrik Jan
    Atmodimedjo, Peggy N.
    Kros, Johan M.
    Vincent, Arnaud J. P. E.
    van den Bent, Martin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
    Prajwal Ghimire
    Ahmad Kamaludin
    Berta F. Palau
    Jose P. Lavrador
    Richard Gullan
    Francesco Vergani
    Ranjeev Bhangoo
    Keyoumars Ashkan
    Acta Neurochirurgica, 166 (1)
  • [5] Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients
    Hallaert, Giorgio
    Pinson, Harry
    Vanhauwaert, Dimitri
    Van den Broecke, Caroline
    Van Roost, Dirk
    Boterberg, Tom
    Kalala, Jean-Pierre
    SURGICAL ONCOLOGY-OXFORD, 2020, 35 : 515 - 519
  • [6] Is surgical resection predict overall survival in frail patients with glioblastoma, IDH-wildtype?
    Elia, A.
    Bertuccio, A.
    Vitali, M.
    Barbaner, A.
    Pallud, J.
    NEUROCHIRURGIE, 2023, 69 (02)
  • [7] DNA METHYLATION SUBCLASSES PREDICT THE BENEFIT FROM GROSS TOTAL TUMOR RESECTION IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS
    Drexler, Richard
    Schueller, Ulrich
    Eckhardt, Alicia
    Filipski, Katharina
    Hartung, Tabea
    Harter, Patrick
    Dive, Iris
    Forster, Marie-Therese
    Czabanka, Marcus
    Jelgersma, Claudius
    Onken, Julia
    Vajkoczy, Peter
    Capper, David
    Siewert, Christin
    Sauvigny, Thomas
    Lamszus, Katrin
    Westphal, Manfred
    Duehrsen, Lasse
    Ricklefs, Franz
    NEURO-ONCOLOGY, 2022, 24 : 11 - 11
  • [8] DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients
    Drexler, Richard
    Schueller, Ulrich
    Eckhardt, Alicia
    Filipski, Katharina
    Hartung, Tabea, I
    Harter, Patrick N.
    Dive, Iris
    Forster, Marie-Therese
    Czabanka, Marcus
    Jelgersma, Claudius
    Onken, Julia
    Vajkoczy, Peter
    Capper, David
    Siewert, Christin
    Sauvigny, Thomas
    Lamszus, Katrin
    Westphal, Manfred
    Duehrsen, Lasse
    Ricklefs, Franz L.
    NEURO-ONCOLOGY, 2023, 25 (02) : 315 - 325
  • [9] Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
    Teske, Nico
    Karschnia, Philipp
    Weller, Jonathan
    Siller, Sebastian
    Dorostkar, Mario M.
    Herms, Jochen
    von Baumgarten, Louisa
    Tonn, Joerg Christian
    Thon, Niklas
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (02) : 317 - 327
  • [10] Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
    Nico Teske
    Philipp Karschnia
    Jonathan Weller
    Sebastian Siller
    Mario M. Dorostkar
    Jochen Herms
    Louisa von Baumgarten
    Joerg Christian Tonn
    Niklas Thon
    Journal of Neuro-Oncology, 2022, 156 : 317 - 327
12345